Dr Chris Behrenbruch’s ASX Longtail was a very insightful, humorous and to the point blog. He certainly didn’t hold back on several companies including Starpharma. I tip my hat to his scientific entrepreneurship and business acumen for founding TLX and building the company up to $3B value. They also just announced they are listing in the USA.
Out of respect for Chris I have requested the post be removed, even though his burning assessment of Starpharma is already in the public domain on other Hotcopper threads from previous years.
Of note, I went back and had a look at Starpharma’s ASX release regarding DEP Herceptin in 2015 and guess what?
‘We are very excited by these latest results for our targeted DEP™ conjugates and feedback from commercial parties on this new data has been very positive indeed. Discussions are now underway with a number of pharmaceutical companies…’
Meanwhile, 8 years later …
Ring a bell?
Dr Chris Behrenbruch’s ASX Longtail was a very insightful,...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.002(2.04%) |
Mkt cap ! $41.73M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.5¢ | 9.9¢ | $49.15K | 486.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 65751 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 226460 | 3 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |